Stefano Di Bella is an expert in Infectiology at Azienda Sanitaria Universitaria Integrata di Trieste (Italy). As of October 2026, ScienceLeadR ranks Stefano Di Bella in the top 1% of experts worldwide for Pneumonia. Stefano Di Bella has authored 210 publications, the most recent in 2026, and is an investigator in 3 clinical trials. SLR score: 735 (community average: 125). How the SLR is computed.

LeadR Profile

735 ScienceLeadR Reputation 735
Network Map

Infectiology

Subspecialties: Biochemistry - Public Health - Internal Medicine

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Short Biography

Stefano Di Bella, MD, is an Infectious Diseases specialist and Associate Professor of Infectious Diseases at the University of Trieste. He is Director of the Infectious Diseases Unit at Trieste University Hospital and Director of the Postgraduate School of Infectious and Tropical Diseases. His clinical and research interests include antimicrobial resistance, antimicrobial therapy, bacterial and fungal infections, Clostridioides difficile infection, sepsis, and emerging infectious diseases. He is actively involved in clinical research, teaching and international scientific collaborations.

Organizations

Career arc: 2011 - 2026

Source: PubMed

Azienda Sanitaria Universitaria Integrata di Trieste

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 210

Citations

Citations: 4 595 1st author: 34 Last author: 34 Unique author: 3


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Carbapenem-Sparing Antimicrobial Stewardship in Internal Medicine: A Prospective Quasi-Experimental Before-and-After Pilot Implementation Study.
PMID 42792026 — pilots, safety, internal medicine, pharmacists, antimicrobial stewardship, fluoroquinolones, meropenem, communicable diseases, carbapenems
Antibiotics (Basel)20260
The critical role of 16S rRNA sequencing in diagnosis and management of an odontogenic deep neck abscess: A case report.
PMID 42757125 — abscess, genes, rrna, diagnosis, rna, ribosomal, 16s, therapeutics, infections
IDCases20260
Tick-Borne Encephalitis in the 21 st Century: Epidemiology, Clinical Challenges, and Prevention Strategies.
PMID 42713406 — epidemiology, vaccines, encephalitis, tick-borne, therapeutics, encephalitis, infections
Infez Med20260
Concomitant oral and genital mucosal involvement in classical Sweet syndrome.
PMID 42687708 — oral ulcer, sweet syndrome
Dermatol Reports20260
In vitro activity and clinical use of cefiderocol against Achromobacter xylosoxidans (Review).
PMID 42683005 — achromobacter denitrificans, achromobacter, infections
Biomed Rep20260

Clinical Studies 3

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 3 2
N/A 1

By status:

Completed 3

By type:

Interventional 2
Observational 1

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 0
multicentric5to9 1
multicentricup10 1

Main Topics

Cohort/Consortium Investigators 3

LeadR Networks

Main global connection map